{"id":"W2050088310","doi":"10.1016/j.exphem.2013.05.205","title":"Effectively targeting treatment-naïve CML stem/progenitor cells from imatinib-nonresponders with combination treatments of new JAK2 and ABL inhibitors in vitro and in vivo","year":2013,"lang":"en","type":"article","venue":"Experimental Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Dasatinib; Progenitor cell; Nilotinib; Stem cell; Imatinib; Pharmacology; Imatinib mesylate; CD34; Medicine; Cancer research; Bone marrow; In vivo; Tyrosine kinase; Tyrosine-kinase inhibitor; Immunology; Internal medicine; Biology; Receptor; Myeloid leukemia; Cell biology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005229971,0.000334883,0.0007604701,0.0002339583,0.00003834363,0.0000137263,0.0000438362,0.0001587363,0.0001093742],"category_scores_gemma":[0.000009936619,0.0002712738,0.00004512067,0.0001427215,0.0001446544,0.0001796035,0.00004890408,0.00009739076,0.00001444125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009599025,"about_ca_system_score_gemma":0.0001206611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005285611,"about_ca_topic_score_gemma":0.0000751179,"domain_scores_codex":[0.9984306,0.0001368041,0.0004413138,0.0004930844,0.0001649637,0.0003333066],"domain_scores_gemma":[0.9992062,0.0002489096,0.0001807092,0.0001771232,0.00001851089,0.0001685222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002563455,0.001695132,0.1408021,0.00006856416,0.0003006672,0.0002251932,0.006357328,0.000001073671,0.8439761,0.00003926751,0.00009844058,0.003872675],"study_design_scores_gemma":[0.02355352,0.001828189,0.01154575,0.0001604556,0.0000628032,0.0001163035,0.003810889,0.0002523964,0.9584476,0.00003814111,0.000009908917,0.0001740203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931146,0.004717197,0.000003602753,0.00006959204,0.0000751798,0.001805617,0.00001469443,0.00002585105,0.0001736663],"genre_scores_gemma":[0.9970126,0.00004237395,0.002370201,0.00002505751,0.000020633,0.0002854586,0.00004398395,0.00003775044,0.0001619967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1292564,"threshold_uncertainty_score":0.999974,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01124780700506541,"score_gpt":0.2643041934187166,"score_spread":0.2530563864136512,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}